Glytec Appoints Coy Gupta as CTO to Boost AI in Medical Software

Glytec Appoints Coy Gupta as CTO to Boost AI in Medical Software

Glytec has appointed Coy Gupta as Chief Technology Officer to lead its AI and innovation strategy, enhancing its diabetes management platform.

Glytec has appointed Coy Gupta as its new Chief Technology Officer, a move aimed at enhancing the AI capabilities of its industry-leading medical software platform. Gupta, who brings over two decades of experience in enterprise software and healthcare technology, will spearhead Glytec's AI and innovation roadmap. This appointment was announced in a press release.

Gupta's role will focus on addressing the growing demand for intelligent software solutions that improve healthcare outcomes and streamline workflows. His previous leadership roles include positions at Threedium, LetsGetChecked, and BioIQ, where he achieved significant growth and profitability.

Glytec's platform, trusted by over 350 hospitals, is designed to improve diabetes management and insulin dosing. With Gupta's expertise, the company aims to further its commitment to AI-driven innovation and excellence in healthcare technology.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.

Also, consider following us on social media:

Subscribe to Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates

Sponsored

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more